Clin2
NCT05463471Possibly a fitNot yet recruiting

Saline and albumin fluids for fluid-responsive shock

Shock

Treatments studied

Part of Injuries & trauma clinical trials.

This Phase 4 study tests whether giving a balanced salt solution and albumin helps patients whose blood pressure and circulation improve with extra fluids. It is designed for certain adult shock patients who are likely to benefit from fluid “volume expansion.”

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older (any gender).
  • You have shock and need fluid treatment because of poor circulation (for example: low urine output, mental status changes, high lactate, or needing medicines to keep blood pressure up).
  • Doctors think your body may respond to extra fluids, based on bedside fluid-response tests (like PPV/IVC changes, or a passive leg raising test).
  • You are calm enough for the study monitoring (restlessness not obvious; RASS 0 or less).
  • A legal representative can sign the consent form for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05888974Recruiting
Test of heart ultrasound to guide fluids in shock

This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.

Nîmes
NCT02118467Recruiting· Phase 4
Testing medicines that raise blood pressure in ICU shock patients

This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.

Chicago, Illinois
NCT05931601Recruiting· Phase 3
Early blood-pressure support in the emergency department

This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.

Copenhagen
NCT07373717Enrolling by invitation
Comparing fluid tolerance tests in shock patients

This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.

Nanjing, Jiangsu
NCT05148286Recruiting· Phase 4
Testing albumin vs fluids for septic shock in the ER

This trial tests whether giving albumin instead of standard crystalloid fluids helps adults with septic shock. It may improve how well your body circulates blood and reduces strain on organs.

Seoul
NCT06351150Recruiting· Phase 3
Testing angiotensin II for refractory distributive shock

This study tests an injection of angiotensin II (a substance that helps tighten blood vessels) versus a placebo for patients with distributive shock that is not responding to standard treatments. It may help raise blood pressure and improve outcomes.

Hefei, Anhui

Hear when a new Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.